While weight loss medications have traditionally been approached with a one-size-fits-all mindset, the recent rise of GLP-1s has sparked a more nuanced conversation, especially when it comes to how men respond to treatment
Polycystic ovary syndrome (PCOS) is a condition that affects hormonal balance, affecting 6-10% of reproductive-aged women ( 1 )
While the proposed contract year 2026 Medicare Advantage and Part D rule initially included language that would have expanded coverage for weight loss medications, those provisions were removed from the final rule
That means that the muscles someone has in their forties and fifties becomes a very important foundation for the decades that follow, which is why when weight loss centers the picture, whether through lifestyle changes or medications like GLP ones, protecting muscle becomes even more important
Diamant M, Van Gaal L, Guerci B, Stranks S, Han J, Malloy J, et al
The clinical relevance of this finding in humans is uncertain, and it is not established as a contraindication in UK Summaries of Product Characteristics for approved GLP-1 receptor agonists